ZIM
ENZ

Zacks Investment Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Zacks Investment Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-47,563
Closed -$388K – 633
2017
Q4 		$388K Sell
47,563
-4,741
-9% -$45.3K 0.01% 477
2017
Q3 		$548K Buy
52,304
+36,629
+234% +$407K 0.01% 450
2017
Q2 		$173K Sell
15,675
-1,873
-11% -$17.5K ﹤0.01% 548
2017
Q1 		$147K Sell
17,548
-38,158
-68% -$269K ﹤0.01% 615
2016
Q4 		$387K Sell
55,706
-115,959
-68% -$740K 0.01% 473
2016
Q3 		$874K Buy
+171,665
New +$1.03M 0.02% 357
2014
Q4 		– Sell
-50,580
Closed -$260K – 766
2014
Q3 		$260K Buy
+50,580
New +$270K 0.01% 574

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Zacks Investment Management's ENZ Position: Q1 2018 in Review

Zacks Investment Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2018, closing a stake of 47,563 shares — an estimated $388K sold.

Zacks Investment Management first reported a position in ENZ in Q3 2014 and held it in 7 quarters. The position peaked at $874K in Q3 2016. 107 funds tracked by Wall St. Rank hold ENZ as of Q1 2018.

  • Zacks Investment Management reported no remaining Enzo Biochem, Inc. position as of Q1 2018 after selling out during the quarter.
  • Zacks Investment Management sold 47,563 Enzo Biochem, Inc. shares in Q1 2018, an estimated $388K.
  • Zacks Investment Management first reported a position in Enzo Biochem, Inc. in Q3 2014 and held it in 7 quarters.
  • Zacks Investment Management's Enzo Biochem, Inc. position peaked at $874K in Q3 2016.
  • 107 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2018.

Based on Zacks Investment Management's 13F filing for Q1 2018, filed 14 May 2018.